Two US patents shielding Impax’ Zomig (zolmitriptan) nasal spray are not invalid, a US Court of Appeals has affirmed, upholding an unfavourable lower court ruling against abbreviated new drug application (ANDA) filer Lannett.
Two US patents shielding Impax’ Zomig (zolmitriptan) nasal spray are not invalid, a US Court of Appeals has affirmed, upholding an unfavourable lower court ruling against abbreviated new drug application (ANDA) filer Lannett.
The US player had appealed against Delaware District Judge Richard Andrews’ finding that US formulation patents 6,750,237 and 7,220,767 were...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
